Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism

Oncogene

Volumn 35, Issue 22, 2016, Pages 2881-2892

  Sartorius, C A ^a   Hanna, C T ^a   Gril, B ^b   Cruz, H ^a   Serkova, N J ^a   Huber, K M ^a   Kabos, P ^a   Schedin, T B ^a   Borges, V F ^a   Steeg, P S ^b   Cittelly, D M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; LETROZOLE; MESSENGER RNA; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN METASTASIS; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPLEMENTATION; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; ANIMAL; BRAIN TUMOR; CELL MOTION; CELL TRANSFORMATION; DRUG EFFECTS; GENE SILENCING; METABOLISM; NUDE MOUSE; PATHOLOGY; SECONDARY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; ASTROCYTES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; ESTRADIOL; ESTROGENS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84962266084     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.353     Document Type: Article

References (55)

1. Cheng X, Hung MC. Breast cancer brain metastases. Cancer Metastasis Rev 2007; 26: 635-643.
2. Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D et al. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res 2011; 17: 4834-4843.
3. Kodack DP, Askoxylakis V, Ferraro GB, Fukumura D, Jain RK. Emerging strategies for treating brain metastases from breast cancer. Cancer Cell 2015; 27: 163-175.
4. Boogerd W, Vos VW, Hart AA, Baris G. Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol 1993; 15: 165-174.
5. Braccini AL, Azria D, Thezenas S, Romieu G, Ferrero JM, Jacot W. Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies. Breast 2013; 22: 993-998.
6. Evans AJ, James JJ, Cornford EJ, Chan SY, Burrell HC, Pinder SE et al. Brain metastases from breast cancer: identification of a high-risk group. Clin Oncol (R Coll Radiol) 2004; 16: 345-349.
7. Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ et al. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. Am J Surg Pathol 2006. 1097-1104.
8. Kaal ECA, CGJH Niël, Vecht CJ. Therapeutic management of brain metastasis. Lancet Neurol 2005; 4: 289-298.
9. Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol 2004; 22: 3608-3617.
10. Tham Y-L, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006; 107: 696-704.
11. Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong Y-N et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.Cancer 2012; 118: 5463-5472.
12. Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 1983; 23: 175-180.
13. Lee SS, Ahn J-H, Kim MK, Sym SJ, Gong G, Ahn SD et al. Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat 2007; 111: 523-530.
14. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983; 52: 2349-2354.
15. Hung MH, Liu CY, Shiau CY, Hsu CY, Tsai YF, Wang YL et al. Effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients. PLoS ONE 2014; 9: e89389.
16. García-Ovejero D, Veiga S, García-Segura LM, Doncarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 2002; 450: 256-271.
17. Morissette M, Le Saux M, D'Astous M, Jourdain S, Al Sweidi S, Morin N et al. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J Steroid Biochem Mol Biol 2008; 108: 327-338.
18. Pettersson K, Gustafsson J-Å. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001; 63: 165-192.
19. Razmara A, Sunday L, Stirone C, Wang XB, Krause DN, Duckles SP et al. Mitochondrial effects of estrogen are mediated by estrogen receptor a in brain endothelial cells. J Pharmacol Exp Ther 2008; 325: 782-790.
20. Arnold S. Estrogen suppresses the impact of glucose deprivation on astrocytic calcium levels and signaling independently of the nuclear estrogen receptor. Neurobiol Dis 2005; 20: 82-92.
21. Barouk S, Hintz T, Li P, Duffy AM, MacLusky NJ, Scharfman HE. 17ß-estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus. Endocrinology 2011; 152: 1745-1751.
22. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001; 63: 29-60.
23. Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE, Hutchison JB. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 1999; 89: 567-578.
24. Montelli S, Peruffo A, Zambenedetti P, Rossipal E, Giacomello M, Zatta P et al. Expression of aromatase P450AROM in the human fetal and early postnatal cerebral cortex. Brain Res 2012; 1475: 11-18.
25. Yague JG, Muñoz A, de Monasterio-Schrader P, Defelipe J, Garcia-Segura LM, Azcoitia I. Aromatase expression in the human temporal cortex. Neuroscience 2006; 138: 389-401.
26. Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM et al. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 2007; 67: 4190-4198.
27. Yoneda T, Williams P, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking cloe in vivo and in vitro. J Bone Miner Res 2001; 16: 1486-1495.
28. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T et al. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 1998; 85: 141-152.
29. Ma YJ, Berg-Von Der Emde K, Moholt-Siebert M, Hill DF, Ojeda SR. Region-Specific Regulation of Transforming Growth Factor Alpha (TGF Alpha) Gene Expression in Astrocytes of the Neuroendocrine Brain. J Neurosci. 1994; 14: 5644-5651.
30. Lee E, Sidoryk-Wegrzynowicz M, Yin Z, Webb A, Son D-S, Aschner M. Transforming growth factor - a mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes. Glia 2012; 60: 1024-1036.
31. Gril B, Palmieri D, Bronder JL, Herring JM, Vega-Valle E, Feigenbaum L et al. Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 2008; 100: 1092-1103.
32. Jenkinson SR, Barraclough R, West CR, Rudland PS. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br J Cancer 2004; 90: 253-262.
33. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 2006; 103: 14825-14830.
34. Arnold S, Victor MB, Beyer C. Estrogen and the regulation of mitochondrial structure and function in the brain. J Steroid Biochem Mol Biol 2012; 131: 2-9.
35. Péqueux C, Raymond-Letron I, Blacher S, Boudou F, Adlanmerini M, Fouque MJ et al. Stromal estrogen receptor - a promotes tumor growth by normalizing an increased angiogenesis. Cancer Res 2012; 72: 3010-3019.
36. Iyer V, Klebba I, McCready J, Arendt LM, Betancur-Boissel M, Wu MF et al. Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Res 2012; 72: 2705-2713.
37. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-292.
38. Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014; 156: 1002-1016.
39. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53.
40. Fidler IJ. The role of the organ microenvironment in brain metastasis. Semin Cancer Biol 2011; 21: 107-112.
41. Gril B, Palmieri D, Qian Y, Anwar T, Liewehr DJ, Steinberg SM et al. Pazopanib inhibits the activation of PDGFRbeta-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells. Am J Pathol 2013; 182: 2368-2379.
42. Kim S-J, Kim J-S, Park ES, Lee J-S, Lin Q, Langley RR et al. Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia 2011; 13: 286-298.
43. Azcoitia I, Santos-Galindo M, Arevalo MA, Garcia-Segura LM. Role of astroglia in the neuroplastic and neuroprotective actions of estradiol. Eur J Neurosci 2010; 32: 1995-2002.
44. Dhandapani KM, Wade FM, Mahesh VB, Brann DW. Astrocyte-derived transforming growth factor-ß mediates the neuroprotective effects of 17ß-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 2005; 146: 2749-2759.
45. Garcia-Segura LM, Torres-Aleman I, Naftolin F. Astrocytic shape and glial fibrillary acidic protein immunoreactivity are modified by estradiol in primary rat hypothalamic cultures. Brain Res Dev Brain Res 1989; 47: 298-302.
46. Dahlmann M, Sack U, Herrmann P, Lemm M, Fichtner I, Schlag PM et al. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation. Oncotarget 2012; 3: 783-797.
47. Wang L, Wang X, Liang Y, Diao X, Chen Q. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Acta Biochim Pol 2012; 59: 593-598.
48. Neman J, Choy C, Kowolik CM, Anderson A, Duenas VJ, Waliany S et al. Co-evolution of breast-to-brain metastasis and neural progenitor cells. Clin Exp Metastasis 2013; 30: 753-768.
49. Wang L, Cossette SM, Rarick KR, Gershan J, Dwinell MB, Harder DR et al. Astrocytes directly influence tumor cell invasion and metastasis in vivo. PLoS ONE 2013; 8: e80933.
50. Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J et al. Breast-cancersecreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 2015; 17: 183-194.
51. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001; 16: 1486-1495.
52. Wu P, Tarasenko YI, Gu Y, Huang LY, Coggeshall RE, Yu Y. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci 2002; 5: 1271-1278.
53. Osborne CK, Hobbs K, Clark GM. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 1985; 45: 584-590.
54. Stanczyk FZ, Mathews BW, Sherman ME. Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current science.Steroids 2015; 99(Pt A): 91-102.
55. Frey L, Lepkin A, Schickedanz A, Huber K, Brown MS, Serkova N. ADC mapping and T1-weighted signal changes on post-injury MRI predict seizure susceptibility after experimental traumatic brain injury. Neurol Res 2014; 36: 26-37.